KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Adaptive Biotechnologies (ADPT) EPS (Basic) (2018 - 2025)

Historic EPS (Basic) for Adaptive Biotechnologies (ADPT) over the last 8 years, with Q3 2025 value amounting to $0.06.

  • Adaptive Biotechnologies' EPS (Basic) rose 12727.27% to $0.06 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.53, marking a year-over-year increase of 6044.78%. This contributed to the annual value of -$1.08 for FY2024, which is 3045.32% up from last year.
  • Per Adaptive Biotechnologies' latest filing, its EPS (Basic) stood at $0.06 for Q3 2025, which was up 12727.27% from -$0.17 recorded in Q2 2025.
  • Adaptive Biotechnologies' EPS (Basic)'s 5-year high stood at $0.06 during Q3 2025, with a 5-year trough of -$0.48 in Q4 2023.
  • In the last 5 years, Adaptive Biotechnologies' EPS (Basic) had a median value of -$0.33 in 2024 and averaged -$0.31.
  • As far as peak fluctuations go, Adaptive Biotechnologies' EPS (Basic) tumbled by 7142.86% in 2023, and later skyrocketed by 12727.27% in 2025.
  • Adaptive Biotechnologies' EPS (Basic) (Quarter) stood at -$0.44 in 2021, then skyrocketed by 36.36% to -$0.28 in 2022, then plummeted by 71.43% to -$0.48 in 2023, then surged by 52.25% to -$0.23 in 2024, then surged by 126.18% to $0.06 in 2025.
  • Its EPS (Basic) was $0.06 in Q3 2025, compared to -$0.17 in Q2 2025 and -$0.2 in Q1 2025.